The Alliance of Community Health Plans (ACHP) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) about the National Coverage Determination (NCD) for beta amyloid pet scans in dementia and neurodegenerative disease patients.
With promising but uncertain treatments of Alzheimer’s actively in development, testing and early usage, now is not the appropriate time to change an NCD that has been in place and working since 2013.
New from ACHP:
- ACHP Letter to Office of Management and Budget Director Vought on Deregulation in Health Care
- Chronic Disease Pledge Bright Spot: Baylor Scott & White Health Plan’s Diabetes Management Program
- ACHP Statement on Energy & Commerce Committee Medicaid Markup
- ACHP Statement on “Most-Favored-Nation” Rx Pricing Executive Order
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
